FARALLON CAPITAL MANAGEMENT LLC - CLOVIS ONCOLOGY INC ownership

CLOVIS ONCOLOGY INC's ticker is and the CUSIP is 189464AC4. A total of 30 filers reported holding CLOVIS ONCOLOGY INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
FARALLON CAPITAL MANAGEMENT LLC ownership history of CLOVIS ONCOLOGY INC
ValueSharesWeighting
Q3 2022$34,585,000
-6.8%
51,910,0000.0%0.19%
-5.9%
Q2 2022$37,116,000
-4.7%
51,910,0000.0%0.20%
+8.0%
Q1 2022$38,933,000
+6.8%
51,910,0000.0%0.19%
+3.3%
Q4 2021$36,467,000
-2.8%
51,910,0000.0%0.18%
+4.0%
Q3 2021$37,511,000
-2.3%
51,910,0000.0%0.18%
+11.5%
Q2 2021$38,401,000
-2.1%
51,910,0000.0%0.16%
-19.5%
Q1 2021$39,243,000
+8.8%
51,910,0000.0%0.20%
-10.1%
Q4 2020$36,077,000
-0.5%
51,910,0000.0%0.22%
-13.5%
Q3 2020$36,272,000
+16.3%
51,910,000
+0.5%
0.25%
+0.4%
Q2 2020$31,197,000
+1.7%
51,672,000
+5.1%
0.25%
-4.9%
Q1 2020$30,671,000
+153.9%
49,172,000
+161.5%
0.26%
+220.7%
Q4 2019$12,080,000
+46.2%
18,801,0000.0%0.08%
+32.3%
Q3 2019$8,261,000
-29.3%
18,801,000
+0.3%
0.06%
-18.4%
Q2 2019$11,684,000
-19.1%
18,750,0000.0%0.08%
-30.3%
Q1 2019$14,438,000
+37.8%
18,750,000
+27.1%
0.11%
+41.6%
Q4 2018$10,475,00014,750,0000.08%
Other shareholders
CLOVIS ONCOLOGY INC shareholders Q2 2019
NameSharesValueWeighting ↓
Jabre Capital Partners S.A. 3,500,000$2,732,0000.90%
SHENKMAN CAPITAL MANAGEMENT INC 8,721,000$6,769,0000.82%
CAMDEN ASSET MANAGEMENT L P /CA 32,275,000$24,949,0000.70%
PFM Health Sciences, LP 57,632,000$44,730,0000.66%
Partner Investment Management, L.P. 768,000$596,0000.46%
SYMPHONY ASSET MANAGEMENT LLC 1,000,000$776,0000.21%
SSI INVESTMENT MANAGEMENT LLC 3,000,000$2,319,0000.18%
PointState Capital LP 12,000,000$9,342,0000.12%
MIZUHO SECURITIES USA LLC 2,000,000$1,548,0000.12%
KINGDON CAPITAL MANAGEMENT, L.L.C. 2,000,000$1,546,0000.11%
View complete list of CLOVIS ONCOLOGY INC shareholders